Join us this March for the first ever CURE Patient-Focused Sessions, taking place at the Miami Breast Cancer Conference! 

To start your customized experience click the start button
Customize ?  
Cancer Types
Quick Links
Award Programs
About Us
Contact Us
Privacy Policy
Terms & Conditions
Face Book
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2018
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.

Breast Cancer

Feature Video
Breast cancer is the second most commonly diagnosed cancer. Because there are many different types of breast cancer and several ways to treat the disease, CURE Connections wants to answer the questions you might have following a recent diagnosis. Throughout this program, you will hear about the different testing procedures that are available for screening, what to do once diagnosed, and how to find the best possible care team, from expert oncologists and breast cancer patients.
Jessica Skarzynski
Cancer survivorship is an important topic that patients and physicians must consider when planning their treatment.
Jessica Skarzynski
For young breast cancer survivors, the type of surgery they recieve to treat their disease can impact their quality of life, according to recent research.
Martha Carlson
Real resolutions to make 2019 feel like a year of finally putting away unachievable goals from the past.
Felicia Mitchell
Making peace with radiation can be a challenge, even if high doses of targeted radiation can silence cancer cells. It took me almost two weeks to tame the beast of fear. What have you done to trick yourself into handling difficult situations during cancer treatment?
Jessica Skarzynski
Here are the top 5 CURE stories for December 2018.
Khevin Barnes
A male breast cancer survivor discovers a challenge even bigger than his disease.
Khevin Barnes
Cancer reminds this survivor that we are much more than our bodies.
Bonnie Annis
Rest is an important part of the healing process for those affected by cancer.
The FDA has approved Herzuma (trastuzumab-pkrb) (Herzuma) as a biosimilar to Herceptin (trastuzumab, Genentech). Trastuzumab-pkrb is a HER2/neu receptor antagonist indicated for the treatment of HER2-overexpressing breast cancer. 
Martha Carlson
Cancer has led me to men and women who grabbed onto life but died anyway.

Sign In

Not a member? Sign up now!
Continue without login

Sign Up

Patient Caregiver Advocate Other